BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 10072428)

  • 1. Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer.
    Richards FM; McKee SA; Rajpar MH; Cole TR; Evans DG; Jankowski JA; McKeown C; Sanders DS; Maher ER
    Hum Mol Genet; 1999 Apr; 8(4):607-10. PubMed ID: 10072428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline mutational analysis of CDH1 and pathologic features in familial cancer syndrome with diffuse gastric cancer/breast cancer proband in a Chinese family.
    Zhu ZG; Yu YY; Zhang Y; Ji J; Zhang J; Liu BY; Chen XH; Lu Y; Jiang HS; Bu L; Hu LD; Kong XY
    Eur J Surg Oncol; 2004 Jun; 30(5):531-5. PubMed ID: 15135482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The E-cadherin gene (CDH1) variants T340A and L599V in gastric and colorectal cancer patients in Korea.
    Kim HC; Wheeler JM; Kim JC; Ilyas M; Beck NE; Kim BS; Park KC; Bodmer WF
    Gut; 2000 Aug; 47(2):262-7. PubMed ID: 10896919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients.
    Oliveira C; Ferreira P; Nabais S; Campos L; Ferreira A; Cirnes L; Alves CC; Veiga I; Fragoso M; Regateiro F; Dias LM; Moreira H; Suriano G; Machado JC; Lopes C; Castedo S; Carneiro F; Seruca R
    Eur J Cancer; 2004 Aug; 40(12):1897-903. PubMed ID: 15288293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer.
    Jonsson BA; Bergh A; Stattin P; Emmanuelsson M; Grönberg H
    Int J Cancer; 2002 Apr; 98(6):838-43. PubMed ID: 11948460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of E-cadherin germ-line alterations with prostate cancer.
    Ikonen T; Matikainen M; Mononen N; Hyytinen ER; Helin HJ; Tommola S; Tammela TL; Pukkala E; Schleutker J; Kallioniemi OP; Koivisto PA
    Clin Cancer Res; 2001 Nov; 7(11):3465-71. PubMed ID: 11705864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E-cadherin germline mutations in familial gastric cancer.
    Guilford P; Hopkins J; Harraway J; McLeod M; McLeod N; Harawira P; Taite H; Scoular R; Miller A; Reeve AE
    Nature; 1998 Mar; 392(6674):402-5. PubMed ID: 9537325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ile-Leu substitution (I415L) in germline E-cadherin gene (CDH1) in Japanese familial gastric cancer.
    Wang Y; Song JP; Ikeda M; Shinmura K; Yokota J; Sugimura H
    Jpn J Clin Oncol; 2003 Jan; 33(1):17-20. PubMed ID: 12604719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond.
    Hansford S; Kaurah P; Li-Chang H; Woo M; Senz J; Pinheiro H; Schrader KA; Schaeffer DF; Shumansky K; Zogopoulos G; Santos TA; Claro I; Carvalho J; Nielsen C; Padilla S; Lum A; Talhouk A; Baker-Lange K; Richardson S; Lewis I; Lindor NM; Pennell E; MacMillan A; Fernandez B; Keller G; Lynch H; Shah SP; Guilford P; Gallinger S; Corso G; Roviello F; Caldas C; Oliveira C; Pharoah PD; Huntsman DG
    JAMA Oncol; 2015 Apr; 1(1):23-32. PubMed ID: 26182300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A germline E-cadherin mutation in a family with gastric and colon cancer.
    Salahshor S; Hou H; Diep CB; Loukola A; Zhang H; Liu T; Chen J; Iselius L; Rubio C; Lothe RA; Aaltonen L; Sun XF; Lindmark G; Lindblom A
    Int J Mol Med; 2001 Oct; 8(4):439-43. PubMed ID: 11562785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline CDH1 mutations are a significant contributor to the high frequency of early-onset diffuse gastric cancer cases in New Zealand Māori.
    Hakkaart C; Ellison-Loschmann L; Day R; Sporle A; Koea J; Harawira P; Cheng S; Gray M; Whaanga T; Pearce N; Guilford P
    Fam Cancer; 2019 Jan; 18(1):83-90. PubMed ID: 29589180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
    van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
    Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline E-cadherin mutations in familial lobular breast cancer.
    Masciari S; Larsson N; Senz J; Boyd N; Kaurah P; Kandel MJ; Harris LN; Pinheiro HC; Troussard A; Miron P; Tung N; Oliveira C; Collins L; Schnitt S; Garber JE; Huntsman D
    J Med Genet; 2007 Nov; 44(11):726-31. PubMed ID: 17660459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer.
    Porter TR; Richards FM; Houlston RS; Evans DG; Jankowski JA; Macdonald F; Norbury G; Payne SJ; Fisher SA; Tomlinson I; Maher ER
    Oncogene; 2002 Mar; 21(12):1928-33. PubMed ID: 11896626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of seven novel germline mutations in the human E-cadherin (CDH1) gene.
    More H; Humar B; Weber W; Ward R; Christian A; Lintott C; Graziano F; Ruzzo AM; Acosta E; Boman B; Harlan M; Ferreira P; Seruca R; Suriano G; Guilford P
    Hum Mutat; 2007 Feb; 28(2):203. PubMed ID: 17221870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDH1/E-cadherin germline mutations in early-onset gastric cancer.
    Bacani JT; Soares M; Zwingerman R; di Nicola N; Senz J; Riddell R; Huntsman DG; Gallinger S
    J Med Genet; 2006 Nov; 43(11):867-72. PubMed ID: 16801346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer.
    Barber M; Murrell A; Ito Y; Maia AT; Hyland S; Oliveira C; Save V; Carneiro F; Paterson AL; Grehan N; Dwerryhouse S; Lao-Sirieix P; Caldas C; Fitzgerald RC
    J Pathol; 2008 Nov; 216(3):295-306. PubMed ID: 18788075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria.
    Brooks-Wilson AR; Kaurah P; Suriano G; Leach S; Senz J; Grehan N; Butterfield YS; Jeyes J; Schinas J; Bacani J; Kelsey M; Ferreira P; MacGillivray B; MacLeod P; Micek M; Ford J; Foulkes W; Australie K; Greenberg C; LaPointe M; Gilpin C; Nikkel S; Gilchrist D; Hughes R; Jackson CE; Monaghan KG; Oliveira MJ; Seruca R; Gallinger S; Caldas C; Huntsman D
    J Med Genet; 2004 Jul; 41(7):508-17. PubMed ID: 15235021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the E-cadherin gene (CDH1) in diffuse gastric cancer susceptibility: from the laboratory to clinical practice.
    Graziano F; Humar B; Guilford P
    Ann Oncol; 2003 Dec; 14(12):1705-13. PubMed ID: 14630673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of CDH1 germline variant location and cancer phenotype in families with hereditary diffuse gastric cancer (HDGC).
    Lo W; Zhu B; Sabesan A; Wu HH; Powers A; Sorber RA; Ravichandran S; Chen I; McDuffie LA; Quadri HS; Beane JD; Calzone K; Miettinen MM; Hewitt SM; Koh C; Heller T; Wacholder S; Rudloff U
    J Med Genet; 2019 Jun; 56(6):370-379. PubMed ID: 30745422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.